The largest database of trusted experimental protocols

2 protocols using hpgds

1

Protein Expression Analysis of Wounded Corneas

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 24 h after debridement, protein samples of the wounded corneas were harvested. For each group, six corneas form six mice were collected. Samples (20 μg) were run on SDS-PAGE and then transferred to a polyvinylidene fluoride (PVDF) membrane. Membranes were blocked with 5% bovine serum albumin (BSA) at room temperature for 2 h and then incubated at 4°C overnight with the primary antibodies against hematopoietic prostaglandin D synthase (Hpgds) (Cayman, 160013), phosphorylated protein kinase B (p-AKT) (Cell Signaling Technology, 4060), AKT (Cell Signaling Technology, 4691), phosphorylated signal transducer and activator of transcription-3 (p-STAT3) (Abcam, ab76315), STAT3 (Cell Signaling Technology, 4904), and β-Actin (Affinity, AF7018), followed by incubation with horseradish peroxidase-conjugated secondary antibodies.
+ Open protocol
+ Expand
2

Eosinophil Signaling Pathways Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified human eosinophils or mouse eosinophils at 2 × 106 cells/mL or 3 × 106 cells/mL in Ca2+/Mg2+ HBSS (HBSS+/+; pH 7.4) were pre-treated with the PI3K inhibitors wortmannin (1 μM; Biomol) and LY294002 (10 μM; Cayman Chemicals), PKC inhibitor calphostin C (1 μM; Biomol), pertussis toxin (PTX; 100 ng/mL), neutralizing monoclonal antibodies anti-CCL5 (10 μg/mL) and anti-CCR3 (10 μg/mL) (both from R&D), the PAF receptor antagonist BN52021 (10 μM), PGD2 receptor antagonists BWA868c (200 nM; DP1 receptor) and Cay10471 (200 nM; DP2 receptor, or PGD2 synthesis inhibitors HQL-79 (10 μM; H-PGDS) and AT-56 (10 μM; L-PGDS) (all from Cayman Chemicals) at 37°C for 30 min before stimulation with human recombinant (hr) or mouse recombinant (mr) leptin (0.5, 5, or 50 nM, as indicated; Peprotech) for 15 or 60 min in a water bath (37°C). Alternatively, eosinophils were also stimulated with PAF (1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine; 1 μM; Cayman Chemicals), hr CCL5 (also known as RANTES−100 ng/mL; R&D) or PGD2 (25 nM; Cayman Chemicals). Each experimental condition was repeated at least three times with eosinophils purified from different donors or differentiated in vitro from different mouse bone marrows.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!